L1 Capital Pty LTD Madrigal Pharmaceuticals, Inc. Transaction History

L1 Capital Pty LTD

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$120.4 - $237.13 $540,716 - $1.06 Million	4,491 Added 9.82%	50,230 $11.6 Million
Q2 2023 Aug 14, 2023	BUY	$203.88 - $312.0 $9.33 Million - $14.3 Million	45,739 New	45,739 $10.6 Million
Q4 2022 Feb 14, 2023	SELL	$58.39 - $296.54 $1.63 Million - $8.26 Million	-27,851 Reduced 17.28%	133,312 $38.7 Million
Q3 2022 Nov 14, 2022	SELL	$60.57 - $79.51 $414,298 - $543,848	-6,840 Reduced 4.07%	161,163 $10.5 Million
Q2 2022 Aug 15, 2022	SELL	$58.04 - $100.2 $2.75 Million - $4.74 Million	-47,313 Reduced 21.97%	168,003 $10.6 Million
Q1 2022 May 16, 2022	BUY	$55.89 - $101.89 $2.66 Million - $4.86 Million	47,655 Added 28.42%	215,316 $15.1 Million
Q4 2021 Feb 14, 2022	BUY	$72.34 - $95.09 $202,624 - $266,347	2,801 Added 1.7%	167,661 $14.2 Million
Q2 2021 Aug 16, 2021	BUY	$97.2 - $137.59 $5.08 Million - $7.19 Million	52,256 Added 46.41%	164,860 $16.1 Million
Q1 2021 May 07, 2021	SELL	$108.54 - $125.2 $93,344 - $107,672	-860 Reduced 0.76%	112,604 $13.2 Million
Q4 2020 Feb 16, 2021	SELL	$110.06 - $133.7 $131,741 - $160,038	-1,197 Reduced 1.04%	113,464 $12.6 Million
Q3 2020 Nov 13, 2020	SELL	$99.78 - $124.21 $266,412 - $331,640	-2,670 Reduced 2.28%	114,661 $13.6 Million
Q2 2020 Aug 14, 2020	BUY	$60.13 - $125.71 $7.06 Million - $14.7 Million	117,331 New	117,331 $13.3 Million

298

21.9M

819K

644K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.81B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of L1 Capital Pty LTD, based on Form 13F filings with the SEC.

Stay updated on L1 Capital Pty LTD with notifications on news.